论文部分内容阅读
目的:探究β-七叶皂苷钠对脑溢血进行治疗的临床效果。方法:选取2013年6月~2014年12月期间到我院进行治疗的80例脑溢血病人作为研究对象,随机分成对照组和研究组,每组40例。对两组患者都采取降血压、补充电解质等对症治疗。研究组患者在对症治疗的基础上增加β-七叶皂苷钠进行治疗。观察两组患者的临床疗效。结果:研究组患者的总有效率为92.5%,明显优于对照组(82.5%),NIHSS评分在治疗第3天和第7天两组数据没有显著性差异(P>0.05);第14和第21天时研究组明显低于对照组,两组数据差异性显著,具有统计学意义(P<0.05)。结论:对脑溢血患者采用β-七叶皂苷钠进行治疗具有显著的临床疗效,可以有效的降低NIHSS评分。值得在临床上推广应用。
Objective: To investigate the clinical effect of β-aescinate on cerebral hemorrhage. Methods: Eighty cerebral hemorrhagic patients who were treated in our hospital from June 2013 to December 2014 were selected as study subjects and randomly divided into control group and study group, 40 cases in each group. The two groups of patients take blood pressure, electrolytes and other symptomatic treatment. Study group patients in the symptomatic treatment based on the increase of β-aescin sodium for treatment. To observe the clinical efficacy of two groups of patients. Results: The total effective rate was 92.5% in the study group, which was significantly better than that in the control group (82.5%). There was no significant difference between the NIHSS scores on the 3rd and 7th day (P> 0.05) On the 21st day, the study group was significantly lower than the control group, with significant difference between the two groups (P <0.05). Conclusion: The treatment of patients with cerebral hemorrhage with β-aescinate has a significant clinical effect, which can effectively reduce the NIHSS score. Worthy of clinical application.